KELSEY HOLZER: Open Payments
NPI 1760051601 · MANDAN, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 55 payments from 14 companies in 2025. Trend: 2023 $1,052 · 2024 $1,360 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $209 |
| AstraZeneca Pharmaceuticals LP | 3 | $184 |
| Lilly USA, LLC | 11 | $143 |
| Astellas Pharma US Inc | 4 | $93 |
| Amgen Inc. | 5 | $74 |
| PFIZER INC. | 4 | $66 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: VRAYLAR, FARXIGA, MOUNJARO, Veozah, NURTEC ODT, JARDIANCE, OTEZLA, UPTRAVI.
Industry payments across ND — which companies pay providers there.
